ostein hydroxyapatite complex
SpainDrugs containing this active substance
-
It is used to prevent the loss of bone mass, as a complementary aid in the treatment of osteoporosis, and to prevent or treat calcium deficiency.
Form: tablets, film-coated
Active substance Dosage ostein hydroxyapatite complex 830 mg ATC: A12A
Manufacturer: Pierre Fabre Iberica S.A.